Efficacy of Low-Dose Chemotherapy Plus Rituximab in Paediatric High Grade Post-Transplant Lymphoproliferative Disease

Guerra-Garcia P.; Raj T. Soosay; Taj M. M.

首页> 外文期刊>Pediatric blood & cancer >Efficacy of Low-Dose Chemotherapy Plus Rituximab in Paediatric High Grade Post-Transplant Lymphoproliferative Disease

【24h】

Efficacy of Low-Dose Chemotherapy Plus Rituximab in Paediatric High Grade Post-Transplant Lymphoproliferative Disease

机译：小剂量化疗加利妥昔单抗在小儿高级别移植后淋巴增生性疾病中的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2016年第3期|共1页
作者
Guerra-Garcia P.; Raj T. Soosay; Taj M. M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of Low-Dose Chemotherapy Plus Rituximab in Paediatric High Grade Post-Transplant Lymphoproliferative Disease [J] . Guerra-Garcia P., Raj T. Soosay, Taj M. M. Pediatric blood & cancer . 2016,第Suppla3期

机译：小剂量化疗加利妥昔单抗在小儿高级别移植后淋巴增生性疾病中的疗效
2. Treatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. [J] . Skoda-Smith S, Douglas VK, Mehta P, Bone marrow transplantation . 2001,第3期

机译：诱导化疗，单倍体外周血干细胞移植和利妥昔单抗治疗移植后淋巴增生性疾病。
3. Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report. [J] . T G Gross, M A Orjuela, S L Perkins, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons . 2012,第11期

机译：小剂量化疗和利妥昔单抗治疗移植后淋巴增生性疾病（PTLD）：儿童肿瘤小组报告。
4. CLASSIFICATION OF CANINE LYMPHOPROLIFERATIVE DISEASES [C] . Davis Seelig Conference of the American College of Veterinary Internal Medicine . 2015

机译：犬淋巴抑制性疾病的分类
5. Treatment and modeling of Epstein-Barr virus post-transplant lymphoproliferative disorder [D] . Jian, Tan Wei. 2016

机译：移栽后淋巴抑制性疾病综合症治疗与建模
6. Low-dose chemotherapy and rituximab for post-transplant lymphoproliferative disease (PTLD): A Childrens Oncology Group report [O] . Thomas G. Gross, Manuela A. Orjuela, Sherrie L. Perkins, -1

机译：低剂量化疗和Rituximab用于移植后淋巴血液疾病（PTLD）：儿童肿瘤学群体报告
7. 29P ALLELE study: A multicenter, open label, phase III study of tabelecleucel for solid organ or allogeneic hematopoietic cell transplant subjects with Epstein-Barr virus-driven post-transplant lymphoproliferative disease (EBV+ PTLD) after failure of rituximab or rituximab and chemotherapy [O] . N. Worel, J.A. Perez-Simon, P. Barba, 2020

机译：29P等级研究：多中心，开放标签，塔伯列皮葡萄酒术的三期研究，用于固体器官或同种异体造血细胞移植受试者，其在Rituximab或Rituximab和化疗失败后的Epstein-Barr病毒驱动后移植后移植后淋巴抑制性疾病（EBV + PTLD）
8. Alpha-v Integrin Targeted PET Imaging of Breast Cancer Angiogenesis and Low-Dose Metronomic Anti-Angiogenic Chemotherapy Efficacy. [R] . Chen, X. 2008

机译：alpha-v整合素靶向pET成像乳腺癌血管生成和低剂量节拍抗血管生成化疗功效。

Efficacy of Low-Dose Chemotherapy Plus Rituximab in Paediatric High Grade Post-Transplant Lymphoproliferative Disease

著录项

相似文献

相关主题

期刊订阅